TrialHepatology (Baltimore, Md.)2015

Randomized trial of interferon- and ribavirin-free ombitasvir/paritaprevir/ritonavir in treatment-experienced hepatitis C virus-infected patients.

Kazuaki Chayama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.